Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany. Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315). 30. September 2019 Sebastian M, Eberhardt WEE, Losem C, Bernhardt C, Maintz C, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert W, Hoffknecht P, Grah C, Rittmeyer A, Griesinger F, Thomas M, 2019. Ann Oncol. 2019;30 (suppl. 5)(1519P (ID: 3970)):mdz260.041 Patients with metastatic non-small cell lung cancer and targetable molecular alterations in Germany. Treatment and first outcome data from the prospective German Registry Platform CRISP (AIO-TRK-0315). Griesinger F, Eberhardt WEE, Nusch A, Reiser M, Zahn MO, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper A, Weichert… Weiterlesen Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany. Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315). Griesinger F, Eberhardt WEE, Bruch HR, Rauh J, von der Heyde E, Marschner N, Jaenicke M, Fleitz A, Spring L, Sahlmann J, Karatas A, Hipper… Weiterlesen